1-2 of 2
Ruggero Mozzana, MD
Close
Sort by
Journal Articles

Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)

Paola Tacchetti, MD, Carolina Terragna, PhD, Gioacchino Catania, MD, Magda Marcatti, MD, Andrea Nozza, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Catello Califano, MD, Anna Baraldi, MD, Andrea Gallamini, MD, Pellegrino Musto, MD, Patrizia Tosi, MD, Piero Galieni, MD, Annalisa Pezzi, Statistician, Francesco Lanza, MD, Michela Ceccolini, MD, Filippo Ballerini, MD, Lucio Catalano, MD, Clotilde Cangialosi, MD, Antonio Lazzaro, MD, Giorgio Paladini, MD, Ruggero Mozzana, MD, Beatrice Anna Zannetti, MD, Graziella Pinotti, MD, Francesca Elice, MD, Michele Baccarani, MD, Mario Boccadoro, MD, Guido Cavaletti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 1821.
https://doi.org/10.1182/blood.V118.21.1821.1821
Published: 2011
Journal Articles

Interphase FISH Analysis Reveals High Frequence of Partial 6q Deletions in Adult Acute Lymphoblastic Leukemia (ALL) with Normal or Failed Karyotype.

Marco Mancini, MD, Paola Gaspari, Daniela Scappaticci, Raffaella Isidori, MS, Cristina Ariola, MS, Loredana Elia, MS, Fabrizio Pane, MD, Francesco Fabbiano, MD, Felicetto Ferrara, MD, Andrea Camera, MD, Caterina Musolino, MD, Luciana Annino, MD, Ruggero Mozzana, MD, Nicola Cantore, MD, Filippo Marmont, MD, Robin Foà, MD
Journal: Blood
Blood (2005) 106 (11): 1460.
https://doi.org/10.1182/blood.V106.11.1460.1460
Published: 2005